Aeterna Inventio is dedicated to the rigorous discovery, validation, and application of biomarkers that enhance clinical decision-making and public health outcomes. We combine multi-omics datasets, polygenic modeling, and phenotypic analysis to generate scientifically robust, reproducible, and ethically governed insights.
Through collaborations with BioArte, LifePlus, and leading academic laboratories, AI-driven predictions are empirically validated and translated into practical, real-world applications.
Our integrated approach enables:
• Early and preventive interventions
• Evidence-based risk stratification
• Data-driven decision-making in healthcare and public health systems
By transforming complex biological data into validated knowledge, Aeterna Inventio bridges research, clinical practice, and societal benefit while maintaining the highest standards of integrity and ethics.
AI-Driven Biomarker Discovery & Validation
Leveraging multi-omics data and advanced computational modeling, we provide predictive insights, experimental validation, and translational applications to support clinical and research decisions.
Predictive Analysis
AI-driven models analyze genomic, proteomic, and clinical datasets to identify biomarkers and generate actionable risk assessments.
Health App & Pilot Studies
Our integrated digital platform supports clinicians and researchers by providing real-time decision support. Pilot studies are underway in public hospitals and private clinics to evaluate usability, clinical relevance, and workflow integration.
Experimental Validation & Polygenic Risk Assessment
Biomarkers are experimentally validated in collaboration with LifePlus, and academic laboratories. Concurrently, polygenic risk scores are calculated to assess individual susceptibility and inform precision medicine strategies.